Overview

A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
A study to compare the safety, pharmacokinetics and pharmacodynamics of YPI 011 to Rabeprazole in healthy adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
Yungjin Pharm. Co., Ltd.
Collaborator:
Seoul National University Hospital
Treatments:
Rabeprazole